MedTrace Logo

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population

NCT00752128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2349

Last updated 2013-04-25

Study results available
· View outcomes & findings →

Summary

The primary objective of the RESOLUTE international registry is to document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a 'real-world' patient population requiring stent implantation.

Conditions

Interventions

DEVICE

Endeavor Resolute Zotarolimus-Eluting Coronary Stent System

Stent implantation

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    collaborator INDUSTRY

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Franz-Josef Neumann, MD · Heart Center Bad Krozingen, Germany

  • Petr Widimský, MD · University Hospital Kralovské Vinohrady, Czech Republic

  • Jorge A. Belardi, MD · Instituto Cardiovascular de Buenos Aires, Argentina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-10-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00752128 on ClinicalTrials.gov